Main Article Content
The article deals with the analysis of the literature on the study of the spectrum of therapeutic properties of Potentilla alba preparation, supplemented with selenium and zinc, which is prescribed in addition to standard management of patients with thyroid hyperfunction. Drug is used alone in subclinical thyrotoxicosis degree I, as well as in achieving stable compensation of diffuse toxic goiter; and as a part of comprehensive therapy — in subclinical thyrotoxicosis degree II, diffuse toxic goiter for normalization of T4 and T3 content in the blood.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343–1421. doi:10.1089/thy.2016.0229.
Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923–931. doi:10.1210/jc.2013-2409.
Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–499. doi:10.1210/jcem.87.2.8182.
Vejbjerg P, Knudsen N, Perrild H, et al. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme. Clin Endocrinol (Oxf). 2009;71(3):440–445. doi:10.1111/j.1365-2265.2008.03493.x.
Biondi B, Bartalena L, Cooper DS, Hegedüs L, Laurberg P, Kahaly GJ. The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyroid J. 2015;4(3):149–163. doi:10.1159/000438750.
Zaharija AV. Doslidzhennja perstachu bilogo jak perspektyvnogo zasobu dlja likuvannja zahvorjuvan' shhytovydnoi' zalozy: eksperymental'ne doslidzhennja. Diss. kand. biol. nauk [Investigation of white cinquefoil as a promising agent for the treatment of thyroid gland diseases: experimental study. PhD in Biol Sci diss.]. Lviv; 1997. 202 p. (in Ukrainian).
Semenova EF, Presniakova EV. The chemical composition of Potentilla alba and its therapeutic use. In: Proceeding of the I Russian scientific-practical conference on Actual problems of innovation with non-traditional plant resources and the creation of functional products. 2001, June 18-19; Moscow, Russian Federation. Chemistry and Computational Simulation. Butlerov Communications. 2001;2(5)(Suppl):32–34. (in Russian).
Shikov AN, Lazukina MA, Pozharitskaya ON, et al. Pharmacological evaluation of Potentilla alba L. in mice: adaptogenic and central nervous system effects. Pharm Biol. 2011;49(10):1023–1028. doi:10.3109/13880209.2011.560162.
Kravchun NA, Kazakov AV, Cherniavskaia IV. Therapeutic correction of autoimmune thyroiditis with hypo- and hyperfunction of the thyroid gland. Problems of Endocrine Pathology. 2010;(3):36–40 (in Russian).
Troshina EA, Senyushkina ES, Terekhova MA. The role of selenium in the pathogenesis of thyroid disease. Klinicheskaia I eksperimentalnaia tiroidologia. 2018;14(4):192–205. doi:10.14341/ket10157 . (in Russian).
Honcharova OA, Illina IM. Selenium deficiency and age-related diseases (in the focus of deiodinase). Mìžnarodnij endokrinologìčnij žurnal. 2015;(68):87–92. doi:10.22141/2224-07220.127.116.115.75020. (in Russian).
Mahmoodianfard S, Vafa M, Golgiri F, et al. Effects of Zinc and Selenium Supplementation on Thyroid Function in Overweight and Obese Hypothyroid Female Patients: A Randomized Double-Blind Controlled Trial. J Am Coll Nutr. 2015;34(5):391–399. doi:10.1080/07315724.2014.926161.